Canadian Online Pharmacy

CDER New June 9, 2014

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

June 6, 2014


New and Generic Drug Approvals

June 5, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Alsuma sumatriptan succinate Injectable;Subcutaneous Meridian Medcl Labeling Revision
Complera emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate Tablet;Oral Gilead Sciences Inc Labeling Revision
Exparel bupivacaine Injectable, Liposomal;Injection Pacira Pharms Inc Manufacturing Change or Addition
Fioricet W/ Codeine acetaminophen; butalbital; caffeine; codeine phosphate Capsule;Oral Watson Labs Inc Manufacturing Change or Addition
Invokana canagliflozin Tablet;Oral Janssen Pharms Manufacturing Change or Addition
Lioresal baclofen Injectable;Intrathecal Medtronic Neuro Manufacturing Change or Addition
Lovaza omega-3-acid ethyl esters Capsule;Oral Smithkline Beecham Manufacturing Change or Addition
Methoxsalen methoxsalen Capsule;Oral Strides Arcolab Ltd Approval
Oxycodone Hydrochloride oxycodone hydrochloride Solution;Oral Coastal Pharms Approval
Procardia Xl nifedipine Tablet, Extended Release;Oral Pfizer Manufacturing Change or Addition
Risperdal Consta risperidone Injectable;Intramuscular Janssen Pharms Manufacturing Change or Addition
Septocaine articaine hydrochloride; epinephrine bitartrate Injectable;Injection Deproco Manufacturing Change or Addition
Sodium Chloride 0.45% In Plastic Container sodium chloride Injectable;Injection Baxter Hlthcare Manufacturing Change or Addition
Sodium Chloride 0.9% In Plastic Container sodium chloride Injectable;Injection Baxter Hlthcare Manufacturing Change or Addition
Suboxone buprenorphine hydrochloride; naloxone hydrochloride Film;Sublingual Reckitt Benckiser Manufacturing Change or Addition
Voltaren diclofenac sodium Tablet, Delayed Release;Oral Novartis Manufacturing Change or Addition
Voltaren-Xr diclofenac sodium Tablet, Extended Release;Oral Novartis Manufacturing Change or Addition

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery